Ποια είναι η τιμή για Bora Pharmaceuticals Co., Ltd. (6472)

Η τιμή για Bora Pharmaceuticals Co., Ltd. (6472) είναι $14.01

Ποια είναι η κεφαλαιοποίηση αγοράς για Bora Pharmaceuticals Co., Ltd. (6472)

Η κεφαλαιοποίηση αγοράς για Bora Pharmaceuticals Co., Ltd. (6472) είναι $1.78B

Bora Pharmaceuticals Co., Ltd. (6472) Τιμή και Κεφαλαιοποίηση Αγοράς

Globally, Bora Pharmaceuticals Co., LTD. is engaged in the comprehensive lifecycle of pharmaceutical products, encompassing research and development, manufacturing, distribution, and sales. The organization operates through key divisions, including Sales, Contract Development & Manufacturing Organization (CDMO), and other ancillary services. Bora produces and markets a diverse range of medicines, from generic and proprietary brand-name drugs to over-the-counter (OTC) remedies. Beyond its in-house portfolio, the company provides extensive contract development and manufacturing solutions. These CDMO services cover all stages of pharmaceutical development, clinical and commercial production, specialized packaging and serialization, rigorous analytical and microbiological quality control, and expert guidance on regulatory compliance. Furthermore, Bora's offerings extend to nutritional supplements, skincare products, and various biotechnical services. The company distributes its goods directly to healthcare facilities such as clinics, pharmacies, and pharmacy chains, as well as to drugstores. It also leverages distributors to supply larger institutions like medical centers, corporate and public hospitals, and regional and district hospitals. Established in 2007, Bora Pharmaceuticals Co., LTD. is based in Taipei City, Taiwan.

Η τιμή για 6472	Το περιουσιακό στοιχείο B	Η κεφαλαιοποίηση αγοράς του B	Αποτελέσματα
$43,424.88 $1.78B	NVDA	$5.532T	+309,912.29%
$36,175.61 $1.78B	AAPL	$4.608T	+258,159.39%
$32,152.05 $1.78B	GOOG	$4.096T	+229,434.99%
$29,426.36 $1.78B	MSFT	$3.748T	+209,976.15%
$21,677.54 $1.78B	AMZN	$2.761T	+154,657.01%

Η τιμή για 6472

Το περιουσιακό στοιχείο B

Η κεφαλαιοποίηση αγοράς του B

Αποτελέσματα

$43,424.88 $1.78B